Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POWER 1 trial of PRAX-628 in adults with focal seizures
2024-514559-13-00Phase 3Completed
- Sponsor
- Praxis Precision Medicines
- Start
- Oct 2024
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 9
01
Overview
Phase 3, randomised, double-blind trial in Focal Onset Epilepsy comparing PRAX-628 with Placebo (2 arms). Started Oct 2024; status: completed.
02
Drugs
vormatrigine
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on 2024-514559-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514559-13-00.